Search results
Results from the WOW.Com Content Network
Diagram showing the site of injection of the product Vasalgel, a vasectomy alternative. Reversible inhibition of sperm under guidance (RISUG), formerly referred to as the synthetic polymer styrene maleic anhydride (SMA), is the development name of a male contraceptive injection developed at IIT Kharagpur in India by the team of Dr. Sujoy K. Guha.
Vasectomy is an effective ... heating could increase the risk of testicular cancer since the inborn birth defect of ... known as Vasalgel, is an adaptation of the ...
On average, the timing for effective contraception was eight weeks. ... Next Life’s approach, called Plan A, or Vasalgel, also involves blocking the vas deferens with a gel-like injection. Next ...
Vasalgel is composed of 25% styrene-alt-maleic acid (SMA acid) dissolved in dimethyl sulfoxide. [9] The major difference between RISUG and Vasalgel is that Vasalgel is composed of SMA acid without SMA anhydride, which allows for a longer shelf-life, smaller probability of hydrolysis to an acid, and less complex production process. [ 9 ]
“The vaccine is well known to be very, very safe and very, very effective, especially against the cancer-causing strains of HPV,” said Dr. Marc Grella, a pediatrician at MassGeneral Hospital ...
At just 19 years old, Eldiara Doucette — known on social media as "Bionic Barbie" — was diagnosed with synovial sarcoma, a rare form of soft tissue cancer that affects only 1,000 people per ...
Founded in 2005, Parsemus is an advocate of research into the plausibility of RISUG (and a method based on RISUG, called Vasalgel), a reversible male contraceptive. [2] [3] The foundation began procuring RISUG's United States intellectual property rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting toxicology tests as an initial ...
Physical activity before cancer diagnosis is associated with a decreased risk of cancer progression and death, a new study, which focused mostly on breast and prostate cancer patients, found.